
Johnson & Johnson cuts size of Covid-19 vaccine study due to prevalence of disease in U.S.
Johnson & Johnson is cutting the size of its pivotal U.S. Covid-19 vaccine trial — the only major study testing a single dose of a Covid vaccine — from 60,000 …
Read More